908 Devices (MASS) Divestments (2025)
908 Devices' (MASS) quarterly Divestments came in at -$8000.0 in Q3 2025, down 100.01% on a QoQ basis from $69.9 million in Q1 2025.
908 Devices (MASS) Divestments (2025) Analysis & Trends
908 Devices (MASS) has 1 years of Divestments data on file, last reported at -$8000.0 in Q3 2025.
- On a quarterly basis, Divestments changed N/A year-over-year to -$8000.0 in Q3 2025; TTM through Dec 2025 was $69.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $69.9 million, changed N/A from the prior year.
- Divestments for Q3 2025 stood at -$8000.0, down from $69.9 million in the prior quarter.
- Over the last five years, Divestments for MASS reached as high as $69.9 million in Q1 2025 and fell as low as -$8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8,000.00 |
| Mar 31, 2025 | 69.92 Mn |